'Twenty years of network meta-analysis: Continuing controversies and recent developments': A health technology assessment perspective.
| Autor: | Jackson D; Statistical Innovation Group, AstraZeneca, Cambridge, UK., Zhang L; Statistical Innovation Group, AstraZeneca, Cambridge, UK., Hettle R; Health Technology Assessment and Modelling Science, AstraZeneca, Cambridge, UK., Cooper M; Oncology Biometrics, AstraZeneca, Cambridge, UK. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Research synthesis methods [Res Synth Methods] 2024 Sep; Vol. 15 (5), pp. 731-734. Date of Electronic Publication: 2024 Jul 30. |
| DOI: | 10.1002/jrsm.1740 |
| Abstrakt: | We respond to some of the methodological issues raised in a recent review of network meta-analysis (NMA). We also provide a health technology developer's perspective and consider the future application of NMA to health technology assessment. (© 2024 John Wiley & Sons Ltd.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|
Plný text